(817) 769-7535


TMS means transcranial magnetic stimulation. It is a non-invasive way to treat depression by sending brief electromagnetic pulses into the brain — similar in kind to the fields used in an MRI. Those pulses are aimed at the brain region research has linked to depression.
Once the device is in place, it delivers a focused magnetic pulse into the left prefrontal cortex. That region often underperforms in depression. Rapid pulses stimulate the neurons there and the emotion-related pathways connected to them, which can help restore healthier function and ease depressive symptoms.
TMS is indicated for adults and teens who have not gotten enough relief from antidepressant medication. A licensed physician must prescribe it. It can be given in inpatient or outpatient settings — clinics, hospitals, or a doctor's office.
​
It is generally well tolerated with few restrictions, but it is not right for everyone. People with non-removable metal in the head (other than braces or dental fillings) are not candidates.
In clinical trials, patients usually received TMS five days a week for about four to six weeks. A course should last at least four weeks; the exact number of sessions depends on your needs and how you respond, and your clinician will set that schedule with you.
Equilibrium's accelerated protocol packs a full clinical course into one to five intensive days, with multiple high-frequency sessions each day under ongoing medical supervision. The goal is to target the relevant pathways quickly and precisely so meaningful improvement — including remission for many people can happen in about a week instead of over months.
Yes. Clinical trials have shown TMS to be safe and well tolerated, and the device is FDA-cleared. Because it is not a drug, it does not carry the systemic side effects people often get from medications.
​
More than 30,000 patients have been treated with TMS. Across the roughly 10,000 treatments in the clinical trials, the most common issues were mild to moderate scalp discomfort and mild headache.
The side effect seen most often in trials was scalp discomfort during sessions, usually mild. People who get migraines often tolerate TMS well, and some notice their migraines improve. Over-the-counter pain relief can help if needed. Large trial datasets support a strong safety profile.
After more than twenty years of research and trials, Health Canada cleared TMS in 2003 and the U.S. FDA cleared it in 2008. It is also approved in Europe, Israel, and Australia. Delivery of treatment is tightly controlled and standardized across these markets.
Most people describe a tapping sensation on the skull. TMS is usually not painful because the induced current does not travel through the skin, where most pain receptors sit. Scalp irritation and headaches are the most common side effects, and they are temporary.
Many people notice change right away or within the first two to three weeks. In clinical trials, more than half of patients had meaningful symptom relief by four weeks. Some improve sooner; others take longer.
For people with severe symptoms, TMS can be transformative. Reported benefits include more energy, better sleep, sharper focus, and stronger relationships.
​
Unlike many medications and some other depression treatments, TMS is not tied to weight gain, sexual side effects, drowsiness, or memory loss. It is non-invasive — no surgery, no sedation — and avoids the usual drug-side effect profile.
​
Although depression was the original use, TMS has also been used for tinnitus, generalized anxiety, OCD, PTSD, postpartum depression, and in some settings for autism, Parkinson's, and Alzheimer's.
No. TMS uses magnetic fields of the same type and strength as MRI, which has been used in tens of millions of patients worldwide without evidence of causing tumors. A full TMS course delivers only a fraction of the magnetic exposure of a single brain MRI. Clinical trials also found no negative effects on memory or concentration.
Antidepressant benefits from TMS have been shown to last beyond twelve months after treatment. In one trial, two out of three patients who had responded or fully remitted still held that improvement a year later. Only about one in three needed follow-up "maintenance" TMS after the study.
No — they are very different. ECT uses electricity to trigger a seizure and requires anesthesia, with serious side effects that can include memory loss. TMS uses magnetic pulses to stimulate specific brain areas without inducing a seizure. It is done in the office, needs no anesthesia, and does not cause systemic side effects.
Antidepressants can cause weight gain, sexual side effects, stomach issues, insomnia, fatigue, and more. TMS is non-systemic — it does not circulate in the bloodstream — so side effects are minimal or none for most people.
Many people who struggle with medication side effects or feel over-medicated hope to reduce their meds during or after TMS. The aim is to reach stable mood first, then lower dose or number of meds when it is appropriate. Many patients have been able to reduce or stop medications while staying stable after TMS, but that is decided case by case under careful clinical monitoring.
Accelerated TMS is usually not covered by commercial insurance or government plans. Costs may be eligible for reimbursement through an FSA. Equilibrium can help with payment options such as credit cards, patient financing loans, and medical credit programs like CareCredit.
Most patients feel a mild tapping sensation on their scalp during treatment. Some experience a mild headache in the first few sessions, which resolves quickly. The vast majority of patients complete their full treatment course comfortably.
Many patients begin noticing improvements around sessions 10–20. Full results are typically seen within 2 weeks, and improvement often continues for weeks after treatment ends.
TMS is especially well-suited for those who have not responded to antidepressants or prefer a non-medication approach. You may not be eligible if you have metal implants in or near your head, a seizure history in the past year, or active psychosis. A consultation will determine your candidacy.
TMS requires no anesthesia, no seizure induction, and causes no memory loss. Patients drive themselves to and from sessions and resume normal daily activities immediately afterward. It is entirely non-invasive.
We do not bill insurance directly, but we provide detailed superbills for self-submission to your carrier. Many patients with major depressive disorder receive partial or full reimbursement. We also offer CareCredit financing.
We offer accelerated protocols with multiple daily sessions, completing your full course in a week.
You may have some questions
